Shaila Ballal
About
In The Last Decade
Shaila Ballal
31 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 66
- Pulmonary and Respiratory Medicine 846
- Physiology 592
- Rheumatology 342
- Immunology 174
- Hematology 112
Countries citing papers authored by Shaila Ballal
This map shows the geographic impact of Shaila Ballal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaila Ballal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaila Ballal more than expected).
Fields of papers citing papers by Shaila Ballal
This network shows the impact of papers produced by Shaila Ballal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaila Ballal. The network helps show where Shaila Ballal may publish in the future.
Co-authorship network of co-authors of Shaila Ballal
This figure shows the co-authorship network connecting the top 25 collaborators of Shaila Ballal. A scholar is included among the top collaborators of Shaila Ballal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaila Ballal. Shaila Ballal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 11 | |
| 4 | 17 | |
| 5 | 147 | |
| 6 | 9 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD breakdown → | 374 |
| 10 | 21 | |
| 11 | 3 | |
| 12 | Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD | 1 |
| 13 | 12 | |
| 14 | 14 | |
| 15 | 24 | |
| 16 | 1 | |
| 17 | 252 | |
| 18 | 1 | |
| 19 | Maintenance of reduction in disease activity and partial remission in patients with Ankylosing spondylitis (AS) - 3-year results from the adalimumab (HUMIRO) trial evaluating long-term efficacy and safety in AS (ATLAS) | 2 |
| 20 | Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitis. | 44 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.